Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: A systematic review.
Hendrea Sanne Aletta TingenAlwin TubbenJ H A van 't OeverE M PastoorP P A van ZonHans L A NienhuisPeter Van der MeerRiemer H J A SlartPublished in: European journal of nuclear medicine and molecular imaging (2023)
F]FBP may not be suitable for the distinction of different types of amyloid cardiomyopathy. No studies on PET in the follow-up of ATTR amyloidosis patients were found. Future research should focus on the use of these PET tracers in the follow-up of ATTR amyloidosis patients.